Foreign Covid vaccine firms can do business here, but on India's terms: Min

Mandaviya also said that the world is astonished by India's vaccination coverage which has reached almost 175 crore, adding that the third Covid-19 wave is on the decline

Mansukh L Mandaviya
Union Health Minister Mansukh L Mandaviya (PTI Photo)
Press Trust of India New Delhi
2 min read Last Updated : Feb 19 2022 | 7:25 AM IST

Union Health Minister Mansukh Mandaviya on Friday said major foreign pharmaceutical companies manufacturing COVID-19 vaccines were demanding indemnity and sovereign immunity waiver to supply their vaccines in India, but the government made it clear that these firms are welcome to do business here but on "our terms".

He was speaking at the launch of a book titled 'A Nation To Protect - Leading India Through The Covid Crisis' and authored by Priyam Gandhi Mody.

On foreign pharma companies wanting to supply vaccines in India, he said, "From the very beginning, we had clarity that foreign vaccine manufacturing companies are welcome to do business in the country, but it has to be on India's terms," the minister asserted.

He further said the terms and conditions put forth by such foreign companies strengthened the concept and determination of developing indigenous vaccines and increasing the production.

"India already had the manpower and brand power, the need was to identify the potential. Prime Minister Narendra Modi was determined and kept on encouraging and motivating scientists and companies," he stated.

Mandaviya also said that the world is astonished by India's vaccination coverage which has reached almost 175 crore, adding that the third COVID-19 wave is on the decline.

He said there have been fewer deaths during the third wave due to large-scale vaccination, except those who died due to co-morbidities and the elderly.

Talking about the criticism faced by the Centre over the vaccination drive, the health minister said opposition leaders like Samajwadi Party president Akhilesh Yadav had questioned the effectiveness of India-made vaccines and refused to take them after terming them BJP vaccines.

A political personality has followers who get influenced by their comments... And a recent study showed how those pockets where the vaccination rate is slow or where it began late were impacted by Covid, he said.

Mandaviya also referred to Congress leader Rahul Gandhi questioning the availability of COVID-19 vaccines in the country. He said the prime minister had asked them not to indulge in politics and stay committed to ensuring that each and every citizen gets vaccinated.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineMansukh Lal MandaviyaVaccine

First Published: Feb 19 2022 | 7:25 AM IST

Next Story